Monopar Therapeutics annual net debt
2021
2022
2023
2024
2025
Monopar Therapeutics Net Debt Growth & History (MNPR)
Monopar Therapeutics's net debt was −$61.6M for fiscal 2025.
View full Monopar Therapeutics company overviewMonopar Therapeutics annual net debt history
| Fiscal year | Period ended | Net debt | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | −$61.6M | −$15.8M | — |
| 2024 | 2024-12-31 | −$45.8M | −$38.6M | — |
| 2023 | 2023-12-31 | −$7.3M | $871,532 | — |
| 2022 | 2022-12-31 | −$8.1M | $12.2M | — |
| 2021 | 2021-12-31 | −$20.3M | — | — |
Monopar Therapeutics quarterly net debt
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Net debt | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | −$52.6M | −$13.2M | — |
| Q1 2026 | 2026-03-31 | −$52.3M | −$12.6M | — |
| Q4 2025 | 2025-12-31 | −$61.6M | −$15.8M | — |
| Q3 2025 | 2025-09-30 | −$127.6M | −$121.6M | — |
| Q2 2025 | 2025-06-30 | −$39.4M | −$33.3M | — |
| Q1 2025 | 2025-03-31 | −$39.7M | — | — |
| Q4 2024 | 2024-12-31 | −$45.8M | −$38.6M | — |
| Q3 2024 | 2024-09-30 | −$6.0M | −$504,731 | — |
| Q2 2024 | 2024-06-30 | −$6.1M | $1.1M | — |
| Q4 2023 | 2023-12-31 | −$7.3M | $871,532 | — |
| Q3 2023 | 2023-09-30 | −$5.5M | $8.7M | — |
| Q2 2023 | 2023-06-30 | −$7.2M | $9.2M | — |
| Q1 2023 | 2023-03-31 | −$5.7M | $12.0M | — |
| Q4 2022 | 2022-12-31 | −$8.1M | $12.2M | — |
| Q3 2022 | 2022-09-30 | −$14.2M | $8.1M | — |
| Q2 2022 | 2022-06-30 | −$16.4M | $7.9M | — |
| Q1 2022 | 2022-03-31 | −$17.8M | $8.0M | — |
| Q4 2021 | 2021-12-31 | −$20.3M | — | — |
| Q3 2021 | 2021-09-30 | −$22.3M | — | — |
| Q2 2021 | 2021-06-30 | −$24.3M | — | — |
| Q1 2021 | 2021-03-31 | −$25.7M | — | — |
Monopar Therapeutics net debt trends
Between the periods ended 2021-12-31 and 2025-12-31, Monopar Therapeutics's net debt decreased from −$20.3M to −$61.6M, a change of −$41.3M. The latest reported quarter, Q2 2026, shows −$52.6M.
About the metric
What net debt means
Net debt compares a company’s interest-bearing debt with its cash and cash equivalents. Positive net debt means debt exceeds cash, while a negative value indicates the company has more cash than debt on this measure.
Calculation and source
How net debt is calculated
TickerStat calculates net debt as total interest-bearing debt minus cash and cash equivalents at the same reporting-period end. Short-term investments are not subtracted because they are not included in the standardized cash series. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Monopar Therapeutics source filings ↗